- Home
- HOTH vs MTEX Comparison
HOTH vs MTEX Comparison
Compare HOTH & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOTH
- MTEX
- Stock Information
- Founded
- HOTH 2017
- MTEX 1993
- Country
- HOTH United States
- MTEX United States
- Employees
- HOTH N/A
- MTEX N/A
- Industry
- HOTH Biotechnology: Pharmaceutical Preparations
- MTEX Medicinal Chemicals and Botanical Products
- Sector
- HOTH Health Care
- MTEX Health Care
- Exchange
- HOTH Nasdaq
- MTEX Nasdaq
- Market Cap
- HOTH 15.6M
- MTEX 15.8M
- IPO Year
- HOTH 2019
- MTEX 1999
- Fundamental
- Price
- HOTH $1.60
- MTEX $7.80
- Analyst Decision
- HOTH Strong Buy
- MTEX
- Analyst Count
- HOTH 3
- MTEX 0
- Target Price
- HOTH $4.00
- MTEX N/A
- AVG Volume (30 Days)
- HOTH 1.8M
- MTEX 10.4K
- Earning Date
- HOTH 11-11-2025
- MTEX 11-11-2025
- Dividend Yield
- HOTH N/A
- MTEX N/A
- EPS Growth
- HOTH N/A
- MTEX N/A
- EPS
- HOTH N/A
- MTEX N/A
- Revenue
- HOTH N/A
- MTEX $112,975,000.00
- Revenue This Year
- HOTH N/A
- MTEX N/A
- Revenue Next Year
- HOTH N/A
- MTEX N/A
- P/E Ratio
- HOTH N/A
- MTEX N/A
- Revenue Growth
- HOTH N/A
- MTEX N/A
- 52 Week Low
- HOTH $0.65
- MTEX $7.05
- 52 Week High
- HOTH $3.80
- MTEX $16.49
- Technical
- Relative Strength Index (RSI)
- HOTH 71.15
- MTEX 41.05
- Support Level
- HOTH $1.40
- MTEX $8.21
- Resistance Level
- HOTH $1.80
- MTEX $9.80
- Average True Range (ATR)
- HOTH 0.11
- MTEX 0.74
- MACD
- HOTH 0.04
- MTEX -0.14
- Stochastic Oscillator
- HOTH 68.75
- MTEX 0.00
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.